| scholarly article | Q13442814 |
| P50 | author | Hans van Bokhoven | Q28324459 |
| Pascal Duijf | Q61086127 | ||
| P2093 | author name string | H G Brunner | |
| D A Haber | |||
| A P Smits | |||
| B C Hamel | |||
| M Bamshad | |||
| A van Haeringen | |||
| A Yang | |||
| F McKeon | |||
| R de Waal | |||
| J Celli | |||
| R C Hennekam | |||
| G Van Buggenhout | |||
| G Vriend | |||
| B Kramer | |||
| A J van Essen | |||
| C G Woods | |||
| R Newbury-Ecob | |||
| P2860 | cites work | p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities | Q22003973 |
| A new human p53 homologue | Q24314918 | ||
| Cloning and functional analysis of human p51, which structurally and functionally resembles p53 | Q24314965 | ||
| The relation between the divergence of sequence and structure in proteins | Q24531519 | ||
| Efficient 12-mutation testing in the CFTR gene: a general model for complex mutation analysis | Q72081702 | ||
| Syndromic ectrodactyly with severe limb, ectodermal, urogenital, and palatal defects maps to chromosome 19 | Q24538677 | ||
| Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations | Q27730815 | ||
| WHAT IF: a molecular modeling and drug design program | Q27860734 | ||
| A comprehensive genetic map of the human genome based on 5,264 microsatellites | Q27860812 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| A simple salting out procedure for extracting DNA from human nucleated cells | Q27861086 | ||
| Physical mapping of the split hand/split foot locus on chromosome 7 and implication in syndromic ectrodactyly | Q28242341 | ||
| Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development | Q28285880 | ||
| p53 mutations in human cancers | Q28302973 | ||
| Mapping the mouse dactylaplasia mutation, Dac, and a gene that controls its expression, mdac | Q28513753 | ||
| p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development | Q28587664 | ||
| p63 is a p53 homologue required for limb and epidermal morphogenesis | Q28588206 | ||
| Database of homology-derived protein structures and the structural meaning of sequence alignment | Q29614393 | ||
| Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers | Q29616471 | ||
| p53: puzzle and paradigm | Q29618407 | ||
| IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools | Q30429006 | ||
| Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. | Q30432624 | ||
| An epidemiological study of isolated split hand/foot in Hungary, 1975-1984. | Q33595589 | ||
| Refined mapping of a gene for split hand-split foot malformation (SHFM3) on chromosome 10q25 | Q33678102 | ||
| Clonal expansion of p53 mutant cells is associated with brain tumour progression | Q34233614 | ||
| Limb mammary syndrome: a new genetic disorder with mammary hypoplasia, ectrodactyly, and other Hand/Foot anomalies maps to human chromosome 3q27 | Q34388906 | ||
| Terminal deletion of the long arm of chromosome 3 [46,XX,del(3)(q27-->qter)]. | Q34734189 | ||
| Systematic screening of yeast artificial-chromosome libraries by use of the polymerase chain reaction | Q34993293 | ||
| Congenital abnormalities associated with limb deficiency defects: a population study based on cases from the Hungarian Congenital Malformation Registry (1975-1984). | Q39400801 | ||
| A second autosomal split hand/split foot locus maps to chromosome 10q24-q25. | Q39419615 | ||
| Pathogenesis of ectrodactyly in the Dactylaplasia mouse: aberrant cell death of the apical ectodermal ridge | Q39457612 | ||
| A comparison of the biological activities of wild-type and mutant p53. | Q40831456 | ||
| Limb mutants: what can they tell us about normal limb development? | Q41601012 | ||
| A second p53-related protein, p73L, with high homology to p73. | Q47688717 | ||
| A novel protein with strong homology to the tumor suppressor p53. | Q48044761 | ||
| X-chromosomally inherited split-hand/split-foot anomaly in a Pakistani kindred. | Q52088295 | ||
| The use of position-specific rotamers in model building by homology | Q71267503 | ||
| Localization of the gene for dominant cystoid macular dystrophy on chromosome 7p | Q71996161 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ectrodactyly–ectodermal dysplasia–cleft syndrome | Q5334319 |
| heterozygosity | Q124059385 | ||
| P304 | page(s) | 143-153 | |
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome | |
| P478 | volume | 99 |
| Q35406330 | 17p13.3 microduplications are associated with split-hand/foot malformation and long-bone deficiency (SHFLD). |
| Q84487842 | A 19-year follow-up of a patient with type 3 ectrodactyly-ectodermal dysplasia-clefting syndrome who developed non-Hodgkin lymphoma |
| Q24321088 | A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism |
| Q77085695 | A de novo mutation (R279C) in the P63 gene in a patient with EEC syndrome |
| Q57721542 | A genome wide linkage scan for cleft lip and palate and dental anomalies |
| Q79249796 | A genome‐wide scan for loci predisposing to non‐syndromic cleft lip with or without cleft palate in two large Syrian families |
| Q30497990 | A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma. |
| Q50674534 | A mutation in TP63 causing a mild ectodermal dysplasia phenotype. |
| Q43168979 | A mutation of the p63 gene in non-syndromic cleft lip. |
| Q52579802 | A new locus for split hand/foot malformation with long bone deficiency (SHFLD) at 2q14.2 identified from a chromosome translocation. |
| Q36869781 | A new mutation in TP63 is associated with age-related pathology |
| Q40121445 | A novel c.1037C > G (p.Ala346Gly) mutation in TP63 as cause of the ectrodactyly-ectodermal dysplasia and cleft lip/palate (EEC) syndrome. |
| Q58328201 | A novel p63 mutation in a fetus with ultrasound detection of split hand/foot malformation |
| Q73836327 | A novel p63 sterile alpha motif (SAM) domain mutation in a Japanese patient with ankyloblepharon, ectodermal defects and cleft lip and palate (AEC) syndrome without ankyloblepharon |
| Q42582134 | A rare association of B cell lymphoma and ectodermal dysplasia presenting with protein-losing enteropathy |
| Q39458140 | A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain |
| Q37895920 | A symphony of regulations centered on p63 to control development of ectoderm-derived structures |
| Q51532702 | ADULT Syndrome Caused by a Mutation Previously Associated with EEC Syndrome |
| Q55981939 | ADULT syndrome due to an R243W mutation in TP63 |
| Q28284341 | APR-246/PRIMA-1(MET) rescues epidermal differentiation in skin keratinocytes derived from EEC syndrome patients with p63 mutations |
| Q34202678 | Acro-cardio-facial syndrome |
| Q33671478 | Addressing the challenges of cleft lip and palate research in India |
| Q43747184 | Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer |
| Q37030292 | Allele-specific silencing of EEC p63 mutant R304W restores p63 transcriptional activity |
| Q28595827 | Altered mRNA Splicing, Chondrocyte Gene Expression and Abnormal Skeletal Development due to SF3B4 Mutations in Rodriguez Acrofacial Dysostosis |
| Q86965856 | An allelic series of Trp63 mutations defines TAp63 as a modifier of EEC syndrome |
| Q37708384 | An etiologic regulatory mutation in IRF6 with loss- and gain-of-function effects. |
| Q56968291 | An unusual combination of EEC syndrome and hypomelanosis Ito due to a p63 mutation |
| Q34264505 | Analysis of large phenotypic variability of EEC and SHFM4 syndromes caused by K193E mutation of the TP63 gene |
| Q24678830 | Analysis of the p63 gene in classical EEC syndrome, related syndromes, and non-syndromic orofacial clefts |
| Q34446570 | Are there CAG repeat expansion-related disorders outside the central nervous system? |
| Q36377830 | Association of generalized aggressive periodontitis and ectrodactyly-ectodermal dysplasia-cleft syndrome |
| Q37439367 | Basal keratinocytes contribute to all strata of the adult zebrafish epidermis. |
| Q36474983 | Bioinformatics methods for identifying candidate disease genes |
| Q39409846 | Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells |
| Q42523322 | CUSP/p63 expression in basal cell carcinoma. |
| Q42509498 | CUSP/p63 expression in rat and human tissues |
| Q33729995 | Cancer risk in persons with oral cleft--a population-based study of 8,093 cases |
| Q40241136 | Cellular networks of human thymic medullary stromas coordinated by p53-related transcription factors |
| Q34790917 | Chronic ulcerative stomatitis |
| Q84548187 | Cleft lip and palate |
| Q33671456 | Cleft lip and palate genetics and application in early embryological development |
| Q36810238 | Cleft lip and palate repair in Hay-Wells/ankyloblepharon-ectodermal dysplasia-clefting syndrome |
| Q24601804 | Cleft lip and palate: understanding genetic and environmental influences |
| Q54782646 | Clinical, genetic, and molecular aspects of split-hand/foot malformation: an update. |
| Q42603581 | Cloning and developmental expression of p73 cDNA in zebrafish |
| Q47807029 | Cloning and expression of the chick p63 gene |
| Q24676916 | Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate |
| Q24321258 | Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains |
| Q92093294 | Comprehensive clinical and molecular studies in split-hand/foot malformation: identification of two plausible candidate genes (LRP6 and UBA2) |
| Q39895605 | Comprehensive mutational analysis and mRNA isoform quantification of TP63 in normal and neoplastic human prostate cells |
| Q77668189 | Conditional inactivation of p63 by Cre-mediated excision |
| Q37951619 | Congenital hair loss disorders: rare, but not too rare |
| Q40238247 | Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice. |
| Q40187458 | Copy-number variants and candidate gene mutations in isolated split hand/foot malformation. |
| Q39020902 | DLX5, FGF8 and the Pin1 isomerase control ΔNp63α protein stability during limb development: a regulatory loop at the basis of the SHFM and EEC congenital malformations |
| Q24600818 | DNA damage in oocytes induces a switch of the quality control factor TAp63α from dimer to tetramer |
| Q33884223 | DNA-binding and transactivation activities are essential for TAp63 protein degradation. |
| Q92237167 | Deletions and loss-of-function variants in TP63 associated with orofacial clefting |
| Q40758235 | Delineating Molecular Mechanisms of Squamous Tissue Homeostasis and Neoplasia: Focus on p63. |
| Q55981940 | Delineation of the ADULT syndrome phenotype due to arginine 298 mutations of the p63 gene |
| Q24645471 | DeltaNp63 knockdown mice: A mouse model for AEC syndrome |
| Q46187718 | Dental and maxillofacial characteristics of six Japanese individuals with ectrodactyly-ectodermal dysplasia-clefting syndrome |
| Q55498386 | Differential PERP regulation by TP63 mutants provides insight into AEC pathogenesis. |
| Q42581268 | Differential effects of p63 mutants on transactivation of p53 and/or p63 responsive genes. |
| Q42527901 | Differential expression of p63 isoforms in normal tissues and neoplastic cells |
| Q28572538 | Differential protein expression, DNA binding and interaction with SV40 large tumour antigen implicate the p63-family of proteins in replicative senescence |
| Q38324246 | Differential recognition of response elements determines target gene specificity for p53 and p63 |
| Q48289265 | Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73. |
| Q28589270 | Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice |
| Q31115438 | Discontinuous microduplications at chromosome 10q24.31 identified in a Chinese family with split hand and foot malformation |
| Q30422189 | Disease-associated mutations disrupt functionally important regions of intrinsic protein disorder |
| Q37679924 | Disrupting hedgehog and WNT signaling interactions promotes cleft lip pathogenesis |
| Q34397705 | Distal limb malformations: underlying mechanisms and clinical associations |
| Q39444688 | Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity |
| Q24535426 | Dlx genes, p63, and ectodermal dysplasias |
| Q28505733 | Dominant-negative retinoic acid receptors elicit epidermal defects through a non-canonical pathway |
| Q41731875 | Drosophila p53 binds a damage response element at the reaper locus |
| Q43923148 | EEC (Ectrodactyly, Ectodermal dysplasia, Clefting) syndrome: heterozygous mutation in the p63 gene (R279H) and DNA-based prenatal diagnosis. |
| Q39184926 | EEC- and ADULT-associated TP63 mutations exhibit functional heterogeneity toward P63 responsive sequences |
| Q34090412 | Ectodermal dysplasias: a new clinical-genetic classification |
| Q34125646 | Ectodermal dysplasias: not only 'skin' deep |
| Q53426670 | Ectrodactyly and Germany's eugenics law of 14 July 1933. |
| Q43151703 | Ectrodactyly-ectodermal dysplasia-clefting syndrome associated with p63 mutation and an uncommon phenotype. |
| Q92104526 | Ectrodactyly-ectodermal dysplasia-clefting syndrome with unusual cutaneous vitiligoid and psoriasiform lesions due to a novel single point TP63 gene mutation |
| Q36924343 | Elucidating common structural features of human pathogenic variations using large-scale atomic-resolution protein networks |
| Q34621360 | Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes |
| Q35279159 | Epidermal Keratinocytes May Have an Important role in Hypertrophic Scarring Pathogenesis: an Immunohistochemical Study (Using P63 and Ki-67 Staining). |
| Q34131395 | Epidermal stem cells: the cradle of epidermal determination, differentiation and wound healing |
| Q34055794 | Exome sequencing reveals a heterozygous DLX5 mutation in a Chinese family with autosomal-dominant split-hand/foot malformation. |
| Q37060334 | Expanding the phenotype of alopecia-contractures-dwarfism mental retardation syndrome (ACD syndrome): description of an additional case and review of the literature |
| Q52745004 | Expanding the phenotypic spectrum of TP63-related disorders including the first set of monozygotic twins. |
| Q42475219 | Expression of p63 and p73 in ameloblastomas |
| Q38445939 | Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin |
| Q41853269 | Expression of p63 in reactive hyperplasias and malignant lymphomas |
| Q64242416 | Expression of p63 in tooth germ, dentigerous cyst and ameloblastoma |
| Q41816694 | Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein |
| Q42439061 | Facial clefting in Tp63 deficient mice results from altered Bmp4, Fgf8 and Shh signaling. |
| Q35130970 | Familial clustering of a rare syndrome |
| Q39067507 | Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness. |
| Q28507692 | Forward genetics identifies Kdf1/1810019J16Rik as an essential regulator of the proliferation-differentiation decision in epidermal progenitor cells |
| Q34164614 | From p63 to p53 across p73. |
| Q55692872 | Functional characterization of a novel TP63 mutation in a family with overlapping features of Rapp-Hodgkin/AEC/ADULT syndromes. |
| Q30479523 | Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity |
| Q36820268 | Gene p63: In ectrodactyly-ectodermal dysplasia clefting, ankyloblepharon-ectodermal dysplasia, Rapp-Hodgkin syndrome |
| Q34688236 | Genetic Syndromes and Genes Involved in the Development of the Female Reproductive Tract: A Possible Role for Gene Therapy. |
| Q52605253 | Genetic analysis of a congenital split‑hand/split‑foot malformation 4 pedigree. |
| Q33906292 | Genetic disorders of the skeleton: a developmental approach |
| Q34276873 | Genetic hair loss |
| Q50936802 | Genetic mapping of agenesis of the third molars in mice. |
| Q37587513 | Genetics of cleft lip and cleft palate. |
| Q34271559 | Genetics of craniofacial development and malformation |
| Q36219320 | Genetics of nonsyndromic orofacial clefts |
| Q40395576 | Genome-wide meta-analyses of nonsyndromic orofacial clefts identify novel associations between FOXE1 and all orofacial clefts, and TP63 and cleft lip with or without cleft palate |
| Q33680682 | Genome-wide profiling of p63 DNA-binding sites identifies an element that regulates gene expression during limb development in the 7q21 SHFM1 locus. |
| Q38154243 | Genomic approaches for studying craniofacial disorders |
| Q28273610 | Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63 |
| Q34460910 | Genomic rearrangement at 10q24 in non-syndromic split-hand/split-foot malformation |
| Q73295770 | Getting a LEAD on EEC |
| Q34749679 | Getting around lethality with inducible Cre-mediated excision |
| Q36177044 | Hair shaft abnormalities--clues to diagnosis and treatment |
| Q40745188 | Heterozygous germline missense mutation in the p63 gene underlying EEC syndrome |
| Q55670365 | Heterozygous mutation in the SAM domain of p63 underlies Rapp-Hodgkin ectodermal dysplasia |
| Q43690426 | High thermostability and lack of cooperative DNA binding distinguish the p63 core domain from the homologous tumor suppressor p53. |
| Q33608769 | Human embryonic stem cell-derived keratinocytes exhibit an epidermal transcription program and undergo epithelial morphogenesis in engineered tissue constructs |
| Q31046841 | Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo |
| Q28579605 | Identification and tissue distribution of novel KET/p63 splice variants |
| Q44207694 | Identification of Dss1 as a 12-O-tetradecanoylphorbol-13-acetate-responsive gene expressed in keratinocyte progenitor cells, with possible involvement in early skin tumorigenesis |
| Q52094726 | Identification of a de novo variant in CHUK in a patient with an EEC/AEC syndrome-like phenotype and hypogammaglobulinemia. |
| Q36294690 | Identification of disease genes by whole genome CGH arrays |
| Q28943326 | Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia |
| Q46931406 | Identification of vitamin D receptor as a target of p63. |
| Q38293557 | Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms |
| Q36598086 | Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246/PRIMA-1MET. |
| Q34531220 | Insertion/deletion polymorphisms in the ΔNp63 promoter are a risk factor for bladder exstrophy epispadias complex |
| Q38130079 | Insights from human genetic studies into the pathways involved in osteoarthritis |
| Q34446991 | Interferon regulatory factor-6: a gene predisposing to isolated cleft lip with or without cleft palate in the Belgian population |
| Q41070135 | Intermediate Phenotype between ADULT Syndrome and EEC Syndrome Caused by R243Q Mutation in TP63 |
| Q50284366 | Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family |
| Q33892334 | Isoforms of DeltaNp63 and the migration of ocular limbal cells in human corneal regeneration |
| Q55040431 | Isolated ectrodactyly caused by a heterozygous missense mutation in the transactivation domain of TP63. |
| Q36947781 | IκB kinase β (IKKβ) inhibits p63 isoform γ (TAp63γ) transcriptional activity |
| Q34291351 | Keratinocyte adhesion and the missing link: from Dowling-Meara to Hay-Wells. St John's Hospital Dermatological Society Annual Oration 2000. |
| Q28280765 | Lacrimoauriculodentodigital syndrome with cleft lip/palate and renal manifestations |
| Q58574758 | Limbal Stem Cell Transplantation: Clinical Results, Limits, and Perspectives |
| Q58327595 | MDM2 and MDMX can interact differently with ARF and members of the p53 family |
| Q34789903 | Marker succession during the development of keratinocytes from cultured human embryonic stem cells |
| Q47286853 | Master regulatory role of p63 in epidermal development and disease |
| Q21563465 | Medical sequencing of candidate genes for nonsyndromic cleft lip and palate |
| Q47786705 | Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence |
| Q52122053 | Mixed clefting type in Rapp-Hodgkin syndrome. |
| Q26996543 | Modeling AEC-New approaches to study rare genetic disorders |
| Q92150026 | Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis |
| Q36581780 | Molecular control of secondary palate development |
| Q34561450 | Molecular-pathogenetic classification of genetic disorders of the skeleton |
| Q28507098 | Mouse model of split hand/foot malformation type I |
| Q57903659 | Mutation in SAM domain of TP63 is associated with nonsyndromic cleft lip and palate and cleft palate |
| Q52547883 | Mutational analysis of HOXD13 and HOXA13 genes in the triphalangeal thumb-brachyectrodactyly syndrome. |
| Q42502045 | Mutations in AEC syndrome skin reveal a role for p63 in basement membrane adhesion, skin barrier integrity and hair follicle biology. |
| Q24600400 | Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes |
| Q34117142 | Mutations in the p53 homolog p63: allele-specific developmental syndromes in humans. |
| Q22254749 | Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia |
| Q34464512 | Normal and abnormal development of the urogenital tract |
| Q50588383 | Novel homozygous mutation, c.400C>T (p.Arg134*), in the PVRL1 gene underlies cleft lip/palate-ectodermal dysplasia syndrome in an Asian patient. |
| Q34399666 | Novel p63 target genes involved in paracrine signaling and keratinocyte differentiation. |
| Q38292032 | Nuclear import and export signals in control of the p53-related protein p73. |
| Q33694956 | OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation |
| Q34511214 | On the shoulders of giants: p63, p73 and the rise of p53. |
| Q26749382 | Oncogenic Intra-p53 Family Member Interactions in Human Cancers |
| Q37394521 | One billion years of p53/p63/p73 evolution |
| Q34185768 | P63 and P73: P53 mimics, menaces and more |
| Q34152571 | P63 gene mutations and human developmental syndromes. |
| Q42435872 | P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues |
| Q91596058 | P63 modulates the expression of the WDFY2 gene which is implicated in cancer regulation and limb development |
| Q36998524 | P63 regulates tubular formation via epithelial-to-mesenchymal transition |
| Q42509601 | P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63? |
| Q39659292 | PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73 |
| Q35545782 | Pathway Regulation of p63, a Director of Epithelial Cell Fate |
| Q38868248 | Phosphorylation and stabilization of TAp63gamma by IkappaB kinase-beta |
| Q38291171 | Physical interaction with human tumor-derived p53 mutants inhibits p63 activities. |
| Q35005194 | Pierre Robin sequence in a patient with ectrodactyly-ectodermal dysplasia-clefting syndrome: a case report and review of the literature |
| Q91809552 | Pioneer and repressive functions of p63 during zebrafish embryonic ectoderm specification |
| Q43169919 | Predicting disease genes using protein-protein interactions. |
| Q36364756 | Prenatal diagnosis for severe inherited skin disorders: 25 years' experience. |
| Q48232224 | Protein aggregation of the p63 transcription factor underlies severe skin fragility in AEC syndrome |
| Q30396003 | Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces |
| Q36925989 | Quality control in oocytes by p63 is based on a spring-loaded activation mechanism on the molecular and cellular level. |
| Q34006360 | RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability |
| Q42240786 | Rapp Hodgkin Syndrome |
| Q36804602 | Regeneration of squamous epithelia from stem cells of cultured grafts. |
| Q33885465 | Regulation and function of the p53-related proteins: same family, different rules |
| Q35103149 | Regulation of Fertility by the p53 Family Members |
| Q36838432 | Repression of Wnt/β-catenin response elements by p63 (TP63) |
| Q35460065 | Role of chromatin and transcriptional co-regulators in mediating p63-genome interactions in keratinocytes |
| Q30454583 | Role of p63 and the Notch pathway in cochlea development and sensorineural deafness |
| Q36284945 | Role of p63 in Development, Tumorigenesis and Cancer Progression |
| Q43472177 | Runx1 is involved in the fusion of the primary and the secondary palatal shelves. |
| Q24534925 | SSRP1 functions as a co-activator of the transcriptional activator p63 |
| Q42841304 | Severe persistent nasolacrimal duct obstruction: a typical finding in ADULT syndrome |
| Q57294154 | Single Cell and Open Chromatin Analysis Reveals Molecular Origin of Epidermal Cells of the Skin |
| Q92623870 | Single-cell RNA-seq identifies a reversible mesodermal activation in abnormally specified epithelia of p63 EEC syndrome |
| Q40782808 | Small players with a big role: MicroRNAs in pathophysiology of cleft lip and palate |
| Q28833410 | Solution structure and binding specificity of the p63 DNA binding domain |
| Q24672616 | Sorting nexin 3 (SNX3) is disrupted in a patient with a translocation t(6;13)(q21;q12) and microcephaly, microphthalmia, ectrodactyly, prognathism (MMEP) phenotype |
| Q35562528 | Special AT-rich binding protein-2 (SATB2) differentially affects disease-causing p63 mutant proteins |
| Q34230565 | Split hand foot malformation is associated with a reduced level of Dactylin gene expression |
| Q42281084 | Split hand/foot malformation syndrome (SHFM): rare congenital orthopaedic disorder |
| Q50493099 | Split hand/split foot malformation with hearing loss: first report of families linked to the SHFM1 locus in 7q21. |
| Q38222736 | Split-hand/feet malformation in three tamilian families and review of the reports from India. |
| Q34141916 | Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. |
| Q77477190 | Split-hand/split-foot malformation with paternal mutation in the p63 gene |
| Q24632741 | Splitting p63 |
| Q24530741 | Strong evidence of linkage disequilibrium between polymorphisms at the IRF6 locus and nonsyndromic cleft lip with or without cleft palate, in an Italian population |
| Q27668032 | Structural basis of p63α SAM domain mutants involved in AEC syndrome |
| Q48875118 | Studies of genes involved in craniofacial development and tumorigenesis: FGF3 contributes to isolated oral clefts and may interact with PAX9. |
| Q46534505 | Surgical treatment options for squamous cell carcinoma of the oral cavity |
| Q30394234 | Systematic analysis of copy number variants of a large cohort of orofacial cleft patients identifies candidate genes for orofacial clefts. |
| Q42487471 | TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53. |
| Q33866001 | TAp63 is a transcriptional target of NF-kappaB. |
| Q24618256 | TAp63 prevents premature aging by promoting adult stem cell maintenance |
| Q38325201 | TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria |
| Q38333551 | TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor. |
| Q35078717 | TP53 family members and human cancers |
| Q55670364 | TP63 gene mutation in ADULT syndrome |
| Q24298312 | Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation |
| Q34784078 | The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations |
| Q36980923 | The Mn1 transcription factor acts upstream of Tbx22 and preferentially regulates posterior palate growth in mice. |
| Q37741331 | The Pu.1 target gene Zbtb11 regulates neutrophil development through its integrase-like HHCC zinc finger. |
| Q52551652 | The Rapp-Hodgkin syndrome results from mutations of the TP63 gene. |
| Q34999137 | The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells |
| Q37383066 | The etiopathogenesis of cleft lip and cleft palate: usefulness and caveats of mouse models |
| Q41999096 | The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection |
| Q24645732 | The first 30 years of p53: growing ever more complex |
| Q40767774 | The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63. |
| Q33849403 | The origins and evolution of the p53 family of genes |
| Q24291822 | The p53 family member genes are involved in the Notch signal pathway |
| Q33298587 | The p53 tumor suppressor-like protein nvp63 mediates selective germ cell death in the sea anemone Nematostella vectensis |
| Q24679311 | The p63 gene in EEC and other syndromes |
| Q104739498 | The power of zebrafish models for understanding the co-occurrence of craniofacial and limb disorders |
| Q38364407 | The role of P-cadherin in skin biology and skin pathology: lessons from the hair follicle |
| Q33899455 | The role of p53 gene family in reproduction |
| Q34283469 | The role of p53 in human cancer |
| Q36890002 | The role of stratifin in fibroblast-keratinocyte interaction |
| Q37471102 | Thymus and aging: morphological, radiological, and functional overview |
| Q37705212 | To grow or not to grow: hair morphogenesis and human genetic hair disorders |
| Q28076789 | Tooth agenesis and orofacial clefting: genetic brothers in arms? |
| Q91724667 | Tooth defects of EEC and AEC syndrome caused by heterozygous TP63 mutations in three Chinese families and genotype-phenotype correlation analyses of TP63-related disorders |
| Q37885627 | Tp63 in oral development, neoplasia, and autoimmunity |
| Q34100529 | Tracing the protectors path from the germ line to the genome |
| Q38851310 | Two case reports with literature review of the EEC syndrome: Clinical presentation and management |
| Q47194658 | Update on 13 Syndromes Affecting Craniofacial and Dental Structures |
| Q35215447 | While p73 is essential, p63 is completely dispensable for the development of the central nervous system |
| Q43997054 | Zebrafish DeltaNp63 is a direct target of Bmp signaling and encodes a transcriptional repressor blocking neural specification in the ventral ectoderm |
| Q34014685 | Zebrafish models of p53 functions |
| Q74031248 | [Congenital malformations: cleft lip and/or palate] |
| Q40407383 | p300 regulates p63 transcriptional activity |
| Q73934817 | p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation |
| Q42509836 | p53 Homologue p63 represses epidermal growth factor receptor expression. |
| Q34313764 | p53 Research: the past thirty years and the next thirty years. |
| Q34106545 | p53 associates with and targets Delta Np63 into a protein degradation pathway |
| Q39918840 | p53 family members regulate the expression of the apolipoprotein D gene. |
| Q42507106 | p53 homologue, p51/p63, maintains the immaturity of keratinocyte stem cells by inhibiting Notch1 activity |
| Q34515770 | p53, p63 and p73--solos, alliances and feuds among family members |
| Q37727778 | p53-family proteins and their regulators: hubs and spokes in tumor suppression |
| Q36443527 | p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. |
| Q33933714 | p53CP is p51/p63, the third member of the p53 gene family: partial purification and characterization |
| Q28510602 | p63 Coordinates anogenital modeling and epithelial cell differentiation in the developing female urogenital tract |
| Q42539520 | p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. |
| Q34483460 | p63 and epithelial biology |
| Q34080237 | p63 and p73, the ancestors of p53. |
| Q30595453 | p63 and p73: old members of a new family |
| Q92522548 | p63 cooperates with CTCF to modulate chromatin architecture in skin keratinocytes |
| Q64076970 | p63 establishes epithelial enhancers at critical craniofacial development genes |
| Q42435899 | p63 expression in normal human epidermis and epidermal appendages and their tumors |
| Q47997667 | p63 expression in sclerosing mucoepidermoid carcinomas with eosinophilia arising in the thyroid |
| Q79346035 | p63 gene analysis in Mexican patients with syndromic and non-syndromic ectrodactyly |
| Q34707172 | p63 identifies keratinocyte stem cells |
| Q53387210 | p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? |
| Q34058121 | p63 in skin development and ectodermal dysplasias |
| Q35227440 | p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. |
| Q36183728 | p63 threonine phosphorylation signals the interaction with the WW domain of the E3 ligase Itch |
| Q33576855 | p63 transcriptionally regulates the expression of matrix metallopeptidase 13. |
| Q80632579 | p63(TP63) elicits strong trans-activation of the MFG-E8/lactadherin/BA46 gene through interactions between the TA and DeltaN isoforms |
| Q37862578 | p63, a story of mice and men. |
| Q34104031 | p63. |
| Q28190562 | p63α Mutations Lead to Aberrant Splicing of Keratinocyte Growth Factor Receptor in the Hay-Wells Syndrome |
| Q28590574 | p73 and p63 protein stability: the way to regulate function? |
| Q44633578 | p73 can suppress the proliferation of cells that express mutant p53. |
| Q40744181 | p73 is expressed in human thymic epithelial cells |
| Q36306728 | p73, a sophisticated p53 family member in the cancer world |
| Q64062966 | ΔNp63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment |
| Q36963424 | ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis |
| Q35897788 | ΔNp63α Transcriptionally Regulates the Expression of CTEN That Is Associated with Prostate Cell Adhesion |
| Q36179548 | ΔNp63α activates CD82 metastasis suppressor to inhibit cancer cell invasion |
| Q41958633 | ΔNp63α is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis |
| Q37656142 | ΔNp63α regulates Erk signaling via MKP3 to inhibit cancer metastasis |
Search more.